Legal status · Canada
Is Abaloparatide legal in Canada?
Yes. Abaloparatide is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Abaloparatide in Canada at a glance
| Classification | Health Canada approved, prescription only |
|---|---|
| Health Canada approval status | Approved by Health Canada for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Abaloparatide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Health Canada has approved Abaloparatide for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Abaloparatide is
An FDA-approved bone-building peptide analogue of parathyroid hormone-related protein for postmenopausal osteoporosis.
Abaloparatide is a synthetic analogue of parathyroid hormone-related protein, approved as Tymlos to build bone in postmenopausal women at high fracture risk. Like teriparatide it stimulates new bone formation with once-daily injection, and trials showed strong fracture reduction.
Mechanism: Selectively activates the PTH1 receptor to favor bone formation over resorption, increasing bone density.
Regulatory history: FDA-approved (Tymlos) for osteoporosis
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Abaloparatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Abaloparatide in other countries
United States
Approved medicineFDA-approved, prescription only
Is Abaloparatide legal in the United States?United Kingdom
Approved medicineLicensed, prescription only (MHRA)
Is Abaloparatide legal in the United Kingdom?Australia
Approved medicineTGA-registered, prescription only
Is Abaloparatide legal in Australia?Frequently asked questions
Is Abaloparatide legal in Canada?
Yes. Abaloparatide is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Abaloparatide in Canada?
Only with a prescription. Abaloparatide is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Abaloparatide Health Canada approved?
Yes, for its labeled indication. In Canada Abaloparatide is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA-approved (Tymlos) for osteoporosis. Evidence level: Strong.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Abaloparatide live on its compound profile.
Abaloparatide profileThis page is general information about the regulatory status of Abaloparatide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.